Skip to main content

USDA Testing Beef for H5N1 Amid Current Outbreak in Dairy Cows

Medically reviewed by Carmen Pope, BPharm. Last updated on May 1, 2024.

By Physician’s Briefing Staff HealthDay Reporter

TUESDAY, April 30, 2024 -- On Monday, the U.S. Department of Agriculture announced that it is now testing ground beef for any presence of the H5N1 virus that continues to spread among dairy cows.

The agency said it is sampling ground beef bought in grocery stores in states where dairy cattle have tested positive for the virus, also known as H5N1, CNN reported. Officials are also testing samples of muscle tissue from sick cows that have been culled from their herd. Last but not least, the USDA is injecting a "virus surrogate" into ground beef and then cooking it at different temperatures to see how much virus is killed under each heat setting.

Still, the agency stressed this testing does not mean the beef supply is not safe.

"USDA is confident that the meat supply is safe. USDA has a rigorous meat inspection process" and "multiple safeguards in place to protect consumers," the agency said in a statement, CNN reported.

"We recommend consumers properly handle raw meats and cook to a safe internal temperature," which kills germs in meat, the agency added.

U.S. health officials are already testing retail milk samples for live bird flu virus, and none has been found in any of the first batch of samples tested, federal health officials said Friday. Those early findings should reassure the public that the milk sold in stores remains safe, officials added.

CNN Article

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted April 2024

Read this next

USDA, HHS Announce New Measures to Monitor, Prevent Bird Flu

FRIDAY, May 10, 2024 -- The U.S. Department of Agriculture and U.S. Department of Health & Human Services have jointly announced a myriad of initiatives aimed at preventing...

COVID-19 Viral Load Rebound Can Occur After VV116, Nirmatrelvir-Ritonavir

WEDNESDAY, March 20, 2024 -- For patients with mild-to-moderate COVID-19, viral load rebound and symptom rebound can occur after a standard five-day course of treatment with VV116...

2023 to 2024 Seasonal Influenza Vaccine Effective for Reducing Risk

THURSDAY, Feb. 29, 2024 -- The 2023 to 2024 seasonal influenza vaccine is effective for reducing the risk for medically attended influenza virus infection, according to research...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.